Home › Surgical Blood Loss › NCT06647017
Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures
Recruiting
Who can join
Ages 18 to 75 · All sexes
Full eligibility criteria
Inclusion Criteria: * Participant is undergoing a dialysis port placement procedure using synthetic graft * Participant is between 18 and 75 years of age * Participant is English proficient * Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements Exclusion Criteria: * Participant has a BMI ≥ 40 * Participant is currently taking a platelet inhibitor medication * Participant has a history of epileptic seizures * Participant has a history of neurological diseases or traumatic brain injury * Participant has presence of devices, e.g., pacemakers, cochlear prosthesis, neurostimulators * Participant has abnormal ear anatomy or ear infection present * Person of childbearing age, not using adequate contraception as per investigator judgment or not willing to comply with contraception for the duration of the study * Person who is pregnant or lactating * Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial
About the study
The objective of this study is to determine if tAN therapy can reduce the volume of blood lost during dialysis AV graft placement procedures.
What is being tested
- Volta tAN System (device)
- SHAM Volta tAN System (device)
Sponsor: University Surgical Vascular · Participants: 40 · Started: Nov 13, 2024
Contact the study team
- David Sailors, MD · Phone: (706) 549-8306
Official record on ClinicalTrials.gov — NCT06647017
Locations in the U.S.
| Georgia | University Surgical Vascular, Watkinsville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.